Self, urine and plasma sampling

• FC 20-01 • Acceptability of self-sampling in New Zealand: a pilot study See abstract > N. N. BREWER • FC 20-02 • Evaluation of high risk HPV DNA detection in self-collected vaginal samples and urine in a test-of-cure setting See abstract > S. S. ANDERSSON • FC 20-03 • Understanding women's perspectives and information needs following a positive HPV self-screening test result See abstract > J. J. TIRO • FC 20-04 • Detection of cervical (pre)cancer on the basis of cervicovaginal fluid: possibilities for development of a selftest. See abstract > D. D. VERSWIJVEL • FC 20-05 • Performance evaluation of a new self-sampling device for HPV detection and genotyping in routine cervical cancer screening See abstract > V. V. COBO • FC 20-06 • Urine human papillomavirus home self-sampling, a promising strategy for enhancement of uterine cervical cancer screening in a large rural French cohort with a 5-year clinical follow-up ( the PAPU29 study) See abstract > C. C. PAYAN • FC 20-07 • Urinary HPV DNA testing as a tool for cervical cancer screening in France See abstract > A. A. DUCANCELLE • FC 20-08 • Is HPV E6 oncoprotein detectable in urine among women with invasive cervical cancer? See abstract > C. C. OLIVEIRA • FC 20-09 • He tapu te whare tangata (the sacred house of mankind): research to inform cervical screening strategies for indigenous Maori women in New Zealand See abstract > B. Beverley Lawton • FC 20-10 • Self-cervical collection for HPV, HHV-2 and HIV-1 detection in women from lower Amazon See abstract > A. A.F. NICOL • FC 20-11 • Utility and factor evaluation of HPV detection based on urine samples in general Chinese women See abstract > H. H. XU • FC 20-12 • Longitudinal study of HPV detection in plasma of women with a recent history of cervical dysplasia See abstract > M. M. MARTINELLI